N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142051 |
| CAS No | NA |
| Mol.F. | C6H6N6O3 |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142052 |
| CAS No | NA |
| Mol.F. | C12H16N6O7 |
| Mol.Wt. | 356.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142053 |
| CAS No | NA |
| Mol.F. | C6H8N6O3 |
| Mol.Wt. | 212.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142054 |
| CAS No | NA |
| Mol.F. | C7H7BrN2O |
| Mol.Wt. | 215.05 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142055 |
| CAS No | NA |
| Mol.F. | C7H8N2O2 |
| Mol.Wt. | 152.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142056 |
| CAS No | NA |
| Mol.F. | C13H13N3O2 |
| Mol.Wt. | 243.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142057 |
| CAS No | NA |
| Mol.F. | C15H17N3O2 |
| Mol.Wt. | 271.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142058 |
| CAS No | NA |
| Mol.F. | C20H29N3O6 |
| Mol.Wt. | 407.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142059 |
| CAS No | NA |
| Mol.F. | C19H27N3O6 |
| Mol.Wt. | 393.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142060 |
| CAS No | 3050754-68-9 |
| Mol.F. | C29H26ClN7O4 |
| Mol.Wt. | 572 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142061 |
| CAS No | NA |
| Mol.F. | C13H12ClN3O2 |
| Mol.Wt. | 277.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142062 |
| CAS No | NA |
| Mol.F. | C24H19CLN6O3 |
| Mol.Wt. | 474.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142063 |
| CAS No | NA |
| Mol.F. | C30H28CLN7O5 |
| Mol.Wt. | 602 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142064 |
| CAS No | NA |
| Mol.F. | C30H28CLN7O6 |
| Mol.Wt. | 618 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142065 |
| CAS No | NA |
| Mol.F. | C15H13N5O2 |
| Mol.Wt. | 295.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142066 |
| CAS No | NA |
| Mol.F. | C15H14ClN5O2 |
| Mol.Wt. | 331.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |